Categories: HealthcareNews

New AAMI Standard on Water Quality for Medical Device Processing

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

Arlington, VA, Aug. 16, 2023 (GLOBE NEWSWIRE) — The Association for the Advancement of Medical Instrumentation (AAMI) has published a new standard that establishes requirements for the quality of water used to process medical devices. The first standard of its kind, ANSI/AAMI ST108:2023, Water for the processing of medical devices, revises and replaces AAMI TIR34:2014/(R)2021, which provided information and guidance on water quality for device reprocessing.

ST108 provides clear requirements for every stage of medical device processing. Matt Williams, AAMI vice president of standards said, “ANSI/AAMI ST108 has garnered an extraordinary amount of interest within the sterile processing, water quality, and regulatory communities and we are excited about its publication. This guidance document will provide much needed information on the minimum requirements for water quality necessary to effectively process medical devices intended for patient use.”

The new standard:

    1. Identifies the categories of water quality that should be used during each stage of sterile processing.
    2. Provides a risk analysis and establishes roles and responsibilities for processing facilities.
    3. Assesses water quality based on factors such as pH, microbial level, conductivity, and other properties.
    4. Establishes maintenance, monitoring, and quality improvement procedures for water treatment systems.
    5. Addresses emergency circumstances such as service interruptions and boil water advisories.

AAMI’s Water Quality for Medical Device Processing Working Group developed ANSI/AAMI ST108 by reaching a consensus on research-based evidence and industry best practices. Its members, including experts from industry, healthcare delivery organizations, regulatory agencies, and academia expect the new standard will have major implications for healthcare providers and the healthcare industry at large.

Terra Kremer, co-chair of AAMI’s Water Quality for Medical Device Processing Working Group said:

The release of this document will be a huge shift for the healthcare industry. The current document AAMI TIR34 makes recommendations, but elevating its content to a standard will encourage healthcare facilities to voluntarily conform with best practices for device processing water quality. 

Erin Kyle, editor in chief of guidelines for perioperative practice at the Association of periOperative Registered Nurses (AORN), stated:

Adoption of this standard will position health care organizations to have confidence that the water that they are using in each stage of reusable medical device processing is achieving the prescribed level of cleanliness and sterilization.

ANSI/AAMI ST108’s novel requirements for water quality provide the foundation for improved patient outcomes and offer clear conformance criteria for organizations involved in processing reusable medical devices in healthcare facilities. For those interested, AAMI will also host an educational session led by Terra Kremer and Erin Kyle on October 5, 2023, to further explain the standard’s requirements.

CONTACT: Dan Visnovsky
Media Relations Manager
dvisnovsky@aami.org
+1 703 215 8483

Staff

Recent Posts

TEN RESEARCHERS HONORED AT ALZHEIMER’S ASSOCIATION INTERNATIONAL CONFERENCE

TORONTO, July 27, 2025 /PRNewswire/ -- The Alzheimer's Association® will present 10 scientific awards at…

12 hours ago

Assembly Biosciences Presents Data Highlighting Recurrent Genital Herpes Program at STI & HIV 2025 World Congress and International Herpesvirus Workshop

– Phase 1a clinical data in healthy participants presented for both ABI-5366 and ABI-1179, novel…

2 days ago

ISS Recommends Shareholders Vote FOR the Merger between Regional Health Properties, Inc. and SunLink Health Systems, Inc.

Atlanta, GA., July 25, 2025 (GLOBE NEWSWIRE) -- Regional Health Properties, Inc. (“Regional”) (OTCBQ: RHEP)…

2 days ago

PharmAla Issues Q3 Financial Statements

TORONTO, July 25, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”)…

2 days ago

Calidi announces Reverse Stock Split, expected to begin trading on a 1-for-12 split adjusted basis on August 5, 2025

SAN DIEGO, July 25, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (“Calidi” or the “Company”)…

2 days ago

Portage Biotech Reports Results for Fiscal Year Ended March 31, 2025

DOVER, Del., July 25, 2025 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (“Portage” or the “Company”)…

2 days ago